These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17886338)

  • 81. The role of chemokines in acute and chronic hepatitis C infection.
    Fahey S; Dempsey E; Long A
    Cell Mol Immunol; 2014 Jan; 11(1):25-40. PubMed ID: 23954947
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo.
    Zhu W; Wu C; Deng W; Pei R; Wang Y; Cao L; Qin B; Lu M; Chen X
    PLoS One; 2012; 7(9):e45146. PubMed ID: 23024803
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Activation of natural killer cells by hepatitis C virus particles in vitro.
    Farag MM; Weigand K; Encke J; Momburg F
    Clin Exp Immunol; 2011 Sep; 165(3):352-62. PubMed ID: 21682720
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C.
    Onomoto K; Morimoto S; Kawaguchi T; Toyoda H; Tanaka M; Kuroda M; Uno K; Kumada T; Matsuda F; Shimotohno K; Fujita T; Murakami Y
    PLoS One; 2011; 6(5):e19799. PubMed ID: 21603632
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection.
    Miyagi T; Shimizu S; Tatsumi T; Nishio K; Hiramatsu N; Kanto T; Hayashi N; Takehara T
    J Gastroenterol; 2011 Aug; 46(8):1020-30. PubMed ID: 21559771
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hepatitis C Virus Evasion from RIG-I-Dependent Hepatic Innate Immunity.
    Liu HM; Gale M
    Gastroenterol Res Pract; 2010; 2010():548390. PubMed ID: 21274284
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The wild-type hepatitis C virus core inhibits initiation of antigen-specific T- and B-cell immune responses in BALB/c mice.
    Zhu W; Chang Y; Wu C; Han Q; Pei R; Lu M; Chen X
    Clin Vaccine Immunol; 2010 Jul; 17(7):1139-47. PubMed ID: 20519445
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy.
    Pang PS; Planet PJ; Glenn JS
    PLoS One; 2009 Aug; 4(8):e6579. PubMed ID: 19668364
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Mechanisms of HCV survival in the host.
    Sklan EH; Charuworn P; Pang PS; Glenn JS
    Nat Rev Gastroenterol Hepatol; 2009 Apr; 6(4):217-27. PubMed ID: 19347013
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes.
    Mengshol JA; Golden-Mason L; Castelblanco N; Im KA; Dillon SM; Wilson CC; Rosen HR;
    Gut; 2009 Jul; 58(7):964-73. PubMed ID: 19193669
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Altered innate immunity in chronic hepatitis C infection: cause or effect?
    Szabo G; Chang S; Dolganiuc A
    Hepatology; 2007 Oct; 46(4):1279-90. PubMed ID: 17886338
    [No Abstract]   [Full Text] [Related]  

  • 92. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
    Bode JG; Brenndörfer ED; Häussinger D
    Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M; Khushboo I; Singh S; Singh S
    Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.
    Hiroishi K; Ito T; Imawari M
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1473-82. PubMed ID: 18761560
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Chronic hepatitis C: virologic and immunologic aspects].
    Moriya K; Koike K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):405-7. PubMed ID: 15359831
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.